These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950 [TBL] [Abstract][Full Text] [Related]
6. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. Godeny EK; Gauntt CJ J Immunol; 1986 Sep; 137(5):1695-702. PubMed ID: 3018079 [TBL] [Abstract][Full Text] [Related]
7. Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3. Lutton CW; Gudvangen RJ; Nealon TJ; Paque RE; Gauntt CJ J Med Virol; 1985 Dec; 17(4):345-57. PubMed ID: 3001222 [TBL] [Abstract][Full Text] [Related]
8. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice. Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777 [TBL] [Abstract][Full Text] [Related]
9. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration. Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068 [TBL] [Abstract][Full Text] [Related]
10. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice. Leipner C; Borchers M; Merkle I; Stelzner A J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212 [TBL] [Abstract][Full Text] [Related]
11. T lymphocyte responses in CVB3-induced murine myocarditis. Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923 [TBL] [Abstract][Full Text] [Related]
12. [A novel DNA vaccine containing endosome-fusogenic peptide prevents CVB3-induced myocarditis in mice]. Xu W; Shen Y; Chen RZ; Xiong SD Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):334-8. PubMed ID: 15059520 [TBL] [Abstract][Full Text] [Related]
13. Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio). Paque RE; Gauntt CJ; Nealon TJ Infect Immun; 1981 Jan; 31(1):470-9. PubMed ID: 6260666 [TBL] [Abstract][Full Text] [Related]
14. Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Trousdale MD; Paque RE; Nealon T; Gauntt CJ Infect Immun; 1979 Feb; 23(2):486-95. PubMed ID: 217832 [TBL] [Abstract][Full Text] [Related]
15. Characterization of anti-heart antibodies in mice after infection with coxsackie B3 virus. Latif N; Zhang H; Archard LC; Yacoub MH; Dunn MJ Clin Immunol; 1999 Apr; 91(1):90-8. PubMed ID: 10219259 [TBL] [Abstract][Full Text] [Related]
16. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. Neumann DA; Rose NR; Ansari AA; Herskowitz A J Immunol; 1994 Jan; 152(1):343-50. PubMed ID: 8254202 [TBL] [Abstract][Full Text] [Related]
17. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3. Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149 [TBL] [Abstract][Full Text] [Related]